Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 15;45(1):371–384. doi: 10.1007/s11357-022-00639-8

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), under exclusive licence to American Aging Association 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

PMC Copyright notice

Fig. 3 — Brain protein carbonyl (oxidative stress marker) differences between angiotensin receptor blockers treated and untreated groups. Levels of brain protein carbonyls (PC) in (A) not cognitively impaired (NCI) group treated (n = 30) and untreated (n = 30) with angiotensin receptor blockers (ARB) and (B) Alzheimer’s dementia (AD) group treated (n = 30) and untreated (n = 30) with ARB. Data are presented with median and interquartile range. Comparisons were conducted using Mann–Whitney U test (ns, non-significant; *p ≤ 0.05)